Investment Overview

Martin and Harris Laboratories Limited is an unlisted company operating in the Health Care sector (Pharmaceuticals). Martin & Harris Laboratories Limited is a pharmaceutical company engaged in contract manufacturing and branded formulations, historically associated with the Apeejay Stya group. The company’s portfolio spans therapeutic segments including anti-infectives, pain management, respiratory and gastro-inte…

Strengths

• Robust Legacy and Brand: Long-standing reputation for quality and reliability boosts consumer trust.
• Diversified Revenue Streams: Pharmaceuticals and investments provide monetary stability and development capability.
• Innovative Product Development: Award-winning innovation strengthens industry leadership and product offerings.

Key Risks

• Dependency on Domestic Markets: Reliance on India exposes the company to local economic and regulatory risks.
• Fluctuating Investment Returns: Market volatility leads to unpredictable returns, affecting monetary consistency.
• Manufacturing Challenges: Expanding production requires steady investment in quality control and infrastructure.

Valuation View

The current unlisted market price is ₹886.05 per share with a market capitalisation of approximately ₹358 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.